Delivery Order SPE2DB22D9151-SPE2DB25FM8FY

Award Date 3/25/25
Potential Completion Date 4/15/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,244.60 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with an ultimate completion date of August 2, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,410.04 firm fixed-price delivery order is for the provision of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,697.84 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 10, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,568.33 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML AUTOINJECTORML, with an ultimate completion date of October 7, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.46 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $3,424.46 for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order contract is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialty pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS...
This federal contract award, valued at $6,848.92, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a completion date of August 12, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,848.92 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
  • SPE2DB22D9151
    Indefinite Delivery Contract
  • SPE2DB22D9151-SPE2DB25FM8FY
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.46 firm fixed-price delivery order is for the supply of 4567720516 - XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a period of performance through April 15, 2025.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This award is not associated with any set-aside designation.

Generated 6/29/25, 1:26 AM